To the full analysis
Imerys stock: growth
NK.PAImerys reported $3.75B in revenue for fiscal 2025, down 6.1% on the prior year, down 2.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
0.2%
per year from 2006 to 2025, per share −0.9%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
−5%
per year from 2006 to 2025, per share −6.1%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −2.3% | −1.9% | 0.2% |
| Revenue per share | −2.8% | −2.5% | −0.9% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −28.0% | −15.0% | −5.0% |
| Free cash flow per share | −28.4% | −15.6% | −6.1% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $3.64B | $210.54M | $157.57M |
| 2007 | $3.77B | $317.91M | $50.97M |
| 2008 | $3.82B | $181.4M | $129.87M |
| 2009 | $3.07B | $45.76M | $423.41M |
| 2010 | $3.71B | $266.83M | $278.69M |
| 2011 | $4.07B | $312.48M | $244.23M |
| 2012 | $4.3B | $322.79M | $241.01M |
| 2013 | $4.1B | $268.16M | $233.48M |
| 2014 | $4.09B | $300.96M | $213.75M |
| 2015 | $4.53B | $75.79M | $302.18M |
| 2016 | $4.62B | $324.45M | $393.6M |
| 2017 | $4.76B | $408M | $311.15M |
| 2018 | $5.09B | $620.09M | $301.51M |
| 2019 | $4.83B | $134.3M | $224.94M |
| 2020 | $4.21B | $33.35M | $305.95M |
| 2021 | $4.06B | $266.05M | $201.23M |
| 2022 | $4.74B | $262.84M | $50.75M |
| 2023 | $4.2B | $56.85M | $226.27M |
| 2024 | $3.99B | −$105.27M | $121.45M |
| 2025 | $3.75B | −$452.99M | $59.17M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Jun 2024)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.